Educational Molecular Tumour Board
Melanoma Institute Australia – Personalised Immunotherapy Program

Please join us for this Educational Molecular Tumour Board Session with presenters from the Melanoma Institute Australia giving insight into their Personalised Immunotherapy Program. This presentation will cover:
– The background around genomic, transcriptomic and tumour immune profiling as biomarkers of response to immunotherapies.
– Biomarker multidisciplinary discussion of somatic, transcriptomic and immune profiling of two patients enrolled in the program.
– Topics covered will include tumour mutation burden, gene expression signatures, quantitative pathology and immunohistochemistry for novel checkpoint ligands.

Speakers
A/Prof James Wilmott. Senior Scientist, Melanoma Institute Australia, The University of Sydney.
Dr Jorja Braden. Medical Oncologist & PhD candidate, Melanoma Institute Australia, The University of Sydney.
Dr Francesca Watts. Pathology Fellow, Melanoma Institute Australia, The University of Sydney.
Dr Tuba Gide. Postdoctoral Researcher, Melanoma Institute Australia, The University of Sydney.

Facilitator
Clinical Professor Rosemary Balleine. Clinical & Strategic Partnerships Lead, Sydney Cancer Partners